WASHINGTON, D.C. – Rep. Earl L. “Buddy” Carter (R-GA) today launched the American-Made Medicines Caucus, a group focused on promoting policies to onshore and friendshore pharmaceutical manufacturing, strengthen our economic and national security interests, and reduce America’s reliance on adversarial countries for essential medications.
The United States is dependent on imports for 90% of all generic drugs and ran a $127 billion trade deficit in pharmaceuticals in 2024.
“China determines whether we have the pharmaceutical products we need in the United States to keep our citizens healthy. That is a terrifying reality, one we must address before the next public health crisis. As a pharmacist, I’m launching the American-Made Medicines Caucus with the singular focus of bringing this critical supply chain home, so that we can strengthen our national security, create jobs, and Make America Healthy Again,” said Rep. Carter.
Founding members of the Caucus include Reps. Claudia Tenney (R-NY) and Gus Bilirakis (R-FL).
“We must continue to support and encourage domestic pharmaceutical medicine production in our country, strengthen our supply chains, reduce our reliance on foreign suppliers, and reinforce our pharmaceutical security. I am eager to join Congressman Carter and Congressman Bilirakis in launching the American-Made Medicines Caucus to focus on creating legislative solutions to improve the domestic production of life-saving medications and antibiotics,” said Rep. Tenney.
“With our overwhelming reliance on Chinese pharmaceutical products and ingredients, it’s imperative that we find ways to increase domestic manufacturing capacity and preserve consumer access to these important and lifesaving products,” Rep. Bilirakis said. “Public health and wellness should not depend on our foreign adversaries, and I look forward to finding ways to address this threat through the Caucus.”
###
